Medication info

Dualtera Tablet 60/5 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Orange, rounded rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202300094 · Approved 2023.01.06

This product's status changed to Approval withdrawn on 2024.02.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine in pediatric and adolescent patients 18 years of age or younger have not been established.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with Pimasartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine in pediatric and adolescent patients 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients allergic to any ingredients of this medication, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with moderate to severe liver impairment, and those with bile duct obstruction should not take this medication. In addition, patients with diabetes or severely impaired renal function, certain genetically lactose-intolerant patients, those with severe aortic stenosis, and patients in shock are also prohibited from taking this medication. Particular caution is required when using this medication in patients with decreased blood volume or sodium deficiency, impaired renal function, renovascular hypertension, heart valve disease, older adults, etc. This medication may cause side effects such as dizziness, headache, swelling, urination problems, insomnia, and facial flushing; consultation with a doctor is necessary if any abnormal symptoms occur. Patients with low blood pressure or electrolyte imbalance may experience symptoms of hypotension when starting this medication or increasing the dose, so caution is necessary, and regular monitoring of serum potassium levels is recommended. This medication may interact with other drugs; therefore, it is essential to inform your doctor, especially if you are taking potassium-sparing diuretics, other antihypertensive medications, lithium, or non-steroidal anti-inflammatory drugs. Use of this medication during pregnancy may pose risks to the fetus, so do not take it if you are planning a pregnancy or are pregnant; it is also not recommended for breastfeeding mothers. The safety of this medication has not been established for children and adolescents under 18, so its use is not recommended. For older adults, no special dose adjustment is necessary, but caution is advised as their body responses may be more sensitive. Patients with moderate to severe liver impairment should not take this medication. In cases of overdose, hypotension, arrhythmia, and in severe cases, shock may occur, so immediate medical attention is required. Store this medication out of the reach of children and do not transfer it to another container; it is essential to follow your doctor's instructions when using it.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial edema
  • peripheral edema
  • urinary disturbance
  • insomnia
  • flushing
  • syncope
  • sedation
Show 128 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • bowel obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • cerebral infarction exacerbation
  • cerebral hemorrhage
  • liver cancer
  • colon adenocarcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • pelvic organ prolapse
  • recurrent cancer
  • chest pain
  • back pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • muscle weakness
  • pharyngitis
  • upper respiratory tract infection
  • epistaxis
  • tension hypertonia
  • sensory decrease
  • paresthesia
  • peripheral neuropathy
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • change in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • epigastric pain
  • diarrhea
  • loose stools
  • constipation
  • skin flushing
  • petechial papular rash
  • dizziness
  • heat sensation
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to light; therefore, it should be stored in a special container that protects it from light. Additionally, it is essential to maintain a temperature between 1 and 30 degrees Celsius while storing the medication. This helps to preserve the efficacy of the medication.

Appearance and packaging

Appearance

Orange, rounded rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.